Johnson & Johnson MedTech

From diagnostic advances to personalized therapies, leading thoracic surgeon Dr. Hammoud discusses the current state of lung cancer and the innovations shaping future treatment as we recognize World Lung Cancer Day. Read this article to learn more: ow.ly/Q3zf50ZuPIL

In a recent webinar, Dr. Sanjog Kalra presented a comprehensive, case-based framework for strategic hemodynamic support in high-risk PCI. Watch the full webinar here: ow.ly/CfaL50ZuFbT This content is intended for US audiences.

The expanded indication for TRUFILL™ n-BCA reflects a rapidly evolving chronic subdural hematoma (cSDH) treatment landscape. Understanding current management challenges and emerging approaches has never been more relevant. Explore the Disease Overview resource today: ow.ly/Xp7550ZuF4c This content is intended for US audiences.

Exciting medtech news from the Middle East: Johnson & Johnson MedTech has introduced the MONARCH™ Platform to the region, enabling the first robotically-assisted bronchoscopy procedures at Cleveland Clinic Abu Dhabi. The milestone also marks the first clinical use of MONARCH™ QUEST AI-enabled navigation in the region, expanding access to innovative technologies that support the early diagnosis of lung cancer. Together, we're advancing what's next in minimally invasive care. #JNJMedTech #MONARCH #RoboticBronchoscopy #LungCancer #HealthcareInnovation ow.ly/mcfj50ZtRoB This content is intended for audiences in the US, Middle East and Africa

We're working with surgeons, clinical teams, and hospitals to advance and develop surgical technologies that transform surgical experiences in harmony with clinical teams in the OR. Read the full article here: ow.ly/kt4B50Zs25c

We're proud to announce the first FDA 510(k) clearance to reprocess the AcuNav CRYSTAL™ and SOUNDSTAR CRYSTAL™ Ultrasound Catheters1,2 — the latest-generation intracardiac echocardiography (ICE) catheters used in cardiac ablation procedures. J&J MedTech's Sustainability Solutions integrates OEM specifications, OEM testing equipment, and OEM expertise directly into the reprocessing experience. That means hospitals and health systems get a reprocessed device built to the same standard as the original — without compromise.3 The result: ✅ Clinical confidence — backed by the same OEM rigor3 ✅ Operational efficiency — streamlined access to next-generation ICE imaging ✅ Financial value — meaningful cost savings without sacrificing performance Learn more: ow.ly/rYRc50Zs1tW This content is intended for US audiences. ACUNAV™ is a trademark of Siemens Medical Solutions USA, Inc.

Introducing CARTOSOUND SONATA™. Designed to guide ablation and concomitant cases using AI-powered anatomical mapping with deeper insights*. Dr. David Weisman, sat down with Fairy Zare, Vice President of Structural Heart and Cardiac Imaging, Johnson & Johnson MedTech, to talk about his experience with this next-gen ultrasound integration. Learn more: ow.ly/VOR850ZrYM3 CARTOSOUND SONATA™. Built for automation, designed for clarity. #Epeeps #Electrophysiology #CARTO #JNJ #CARTOSOUNDSONATA * As compared to CARTOSOUND™ FAM Module This content is intended for US audiences Important Information: Prior to use, refer to the instructions for use for indications, contraindications, side effects, warnings and precautions. Caution: US law restricts this device to sale by or on the order of a physician.

To enable the vast potential of the next era of surgical robotics, it’s essential to use design and engineering to ensure the robot and surgical staff are partners. See how we're advancing and developing technologies to help transform the surgical experience in harmony with clinical teams in the OR. Read the full article here: ow.ly/MSnx50Zs1MY

Last week, we hosted our 2nd annual J&J #ElevateEP event, an immersive educational program that brought together electrophysiologists from around the world who share our commitment to elevating care for patients. Thank you to our Course Directors, faculty, and the entire global #EP community who brought the clinical insights and asked the questions to continue pushing what is possible for patients. At Johnson & Johnson MedTech, we are committed to advance the field through the power of integrated solutions, continuous innovation, and rigorous evidence that helps shape the future of care. We look forward to continuing the discussion at the next #ElevateEP, because we don't just adopt the future. We build it. Together, we Elevate EP. #EPeeps #MedTech US_ELP_ALEL_418636 © Johnson & Johnson and its affiliates 2026

Built to open new possibilities in surgery. Introducing the OTTAVA™ Robotic Surgical System – the world's first table-integrated soft tissue robotic system, now authorized by the U.S. FDA. With its novel table-integrated architecture, automated arm positioning, instrumentation optimized for robotic surgery, and connection to an open digital ecosystem that turns data into actionable insights, OTTAVA offers surgical teams and hospitals more space and more flexibility to operate. Learn more: ow.ly/wXaG50Zrj8V *Intended for U.S. audiences

#NEWS: The U.S. FDA has authorized the OTTAVA™ Robotic Surgical System—the world's first table-integrated soft tissue robotic system. This U.S. milestone reflects years of collaboration with surgeons, engineers and clinical teams to rethink how robotic surgery can better serve clinicians, hospitals and patients. Built to open new possibilities in surgery, OTTAVA is designed with robotic arms integrated directly into the surgical table, a significantly smaller footprint, automated features and connection to an open digital ecosystem designed to turn surgical data into meaningful insights over time. Learn more: social.jnj.com/4bPSceP *Intended for U.S. audiences

Chronic subdural hematoma (cSDH) is one of the most common neurosurgical conditions and its prevalence is expected to continue rising. More than ever, understanding the disease and who is most affected is increasingly crucial. Today, TRUFILL™ n-BCA is indicated for middle meningeal artery (MMA) embolization in symptomatic subacute and chronic cSDH. Neurosurgeons can explore the Disease Overview for more insights on the burden of cSDH. Together, we can shape care and outcomes for patients affected by this disease: ow.ly/79U450ZqLYM

Risk factors are changing. Diagnostic tools are changing. Surgical approaches are evolving, too. What does this mean for the future of colorectal cancer testing and treatment? Read the article to learn more: ow.ly/tvRH50ZiGUe

Winning in the Age of GLP-1s: join bariatric surgery leaders for a virtual panel on integrating obesity medicines into surgical practice. Hear from our featured experts as they cover increasing surgical volume in the GLP-1 era, patient-centric approaches to obesity medicines, the Comprehensive Obesity Care Model, and best practices across academic, ambulatory, and community settings. Register at the links below: 7/29: ow.ly/bGtO50ZnVKf 7/30: ow.ly/TsM250ZnVKg

How can surgical education balance new technology with humanity? Hear what challenges—and potential wins—lie ahead. ow.ly/3CHB50ZnsJa

Heart health conversations matter, especially when it comes to understanding atrial fibrillation (AFib), its risks, and how it can impact overall health. Learn more about AFib in The Balancing Act on Lifetime* featuring host Montel Williams. This educational episode explores why early diagnosis matters, why seeing an AFib specialist is important, and how treatments like catheter ablation utilizing CARTO™ and VARIPULSE™ can help effectively manage AFib. Hear expert insights, a real patient story, and learn more about the evolving landscape of AFib care and treatment technology. View the episode here: ow.ly/PtYa50ZiHeB * This segment was produced by Lifetime, sponsored by Johnson & Johnson #AFibAwareness #HeartHealth #AFibTreatment Disclaimer: Intended for US audiences only. CARTO™ and VARIPULSE™ are medical devices manufactured by Johnson & Johnson MedTech. As with all medical treatments, please discuss which options work best for you. C_US_ELP_TAPE_413173.EN2

Colorectal cancer rates are on the rise, especially among young people—and clinicians and researchers like David Longcope, M.D., a colon and rectal surgeon, are racing to discover why. Learn more at: ow.ly/CzlY50ZiGM8

AI is unlocking new possibilities in healthcare — and exciting opportunities for electrophysiology. We’re staying on the edge of what’s new and what’s next to advance patient care. Join us at #ElevateEP2026 on July 17 with Zack Kass, Eric Topol, MD, Tina Baykaner, MD, MPH, and Nassir Marrouche, MD as they explore AI’s growing influence across healthcare and its potential to transform the field of electrophysiology. Learn more: ow.ly/okuG50Zn1jH #EPeeps #MedTech *Zack Kass, Eric Topol, Tina Baykaner and Nassir Marrouche are compensated by and presenting on behalf of Biosense Webster, Inc., and must present information in accordance with applicable regulatory requirements. US_ELP_ALEL_418650 © Johnson & Johnson and its affiliates 2026

Now available: CARTOSOUND SONATA™ Module. This new CARTO™ AI-powered module is designed for clarity and continues to advance how electrophysiologists map and visualize—now moving from images to deeper insights.* Learn more: ow.ly/2UUu50ZmzcK Built for automation, designed for clarity. CARTOSOUND SONATA™ #Epeeps #Electrophysiology #CARTO #JNJ #CARTOSOUNDSONATA * As compared to CARTOSOUND™ FAM Module This content is intended for US audiences

How is the future of surgical education evolving, and what role will technologies like AI play? Hear from healthcare leaders, and read more about the potential that AI holds in surgery: ow.ly/fRei50ZiGFz